Global Aquaculture Vaccines Market

Report ID : 1388 | Published : 2022-10-06 | Pages: | Format: PDF/EXCEL

The market size of the Global Aquaculture Vaccines Market in the year 2021 is valued at 364.19 million and is predicted to reach 877.67 million by the year 2030 at an 10.51% CAGR during the forecast period.

Vaccination creates or enhances immunity against a particular illness or group of illnesses. There is always a possibility of pathogenic outbreaks in aquaculture methods, impacting the farm's output. Vaccines for aquaculture are used to shield the fish from any infection. Increased demand for food products made from aquatic animals, such as oil, protein powders, caviar, and meat, as well as the rate of disease progression in marine animals, would restrain the growth of the aquaculture vaccines market. Over the forecast period, there is expected to be a rise in demand for commercial aquaculture vaccines due to the increased prevalence of bacterial diseases among aquatic species. The aquaculture vaccine market has also expanded due to rising global demand for and production of aquatic species.

However, the aquaculture vaccinations business has suffered due to the COVID-19 epidemic. Additionally, it's anticipated that short-term market weakness would result from growing knowledge of the risks associated with animal-to-human virus transmission. Moreover, complicated vaccine production processes, high vaccination costs, and strict regulatory requirements for aquaculture vaccine approval would restrain the market's expansion.

Market Segmentation:

The Aquaculture Vaccines market is segmented on the vaccine type, application, route of administration and species. Based on the vaccine type, the market is segmented into Inactivated Vaccine, Attenuated Live Vaccine, DNA Vaccine and Others. Based on application, the Aquaculture Vaccines are segmented into Bacterial Infection, Viral Infections, Combined Bacterial and Viral Infections and Others. Based on route of administration, the market is segmented into Immersion Vaccines, Injection Vaccines and Oral Vaccines. Based on species, the market is segmented into Salmon, Seabass and Seabream, Tilapia, Trout, Turbo and Carp.

Based on the vaccine type, the inactivated vaccines segment is accounted as a major contributor to the Aquaculture Vaccines market.

Inactivated vaccines dominated the market for vaccinations used in aquaculture. Large quantities of the disease-causing microorganisms are fermented to create inactivated bacterial and viral vaccines. Then, inactivating chemicals like formalin are used to eliminate all the germs. These inactivated organisms have their basic structure, original antigen properties, and form, which causes an immune response. The recombinant vaccines market is projected to expand significantly. Recombinant vaccines can imitate naturally occurring illnesses and induce a potent immune response in inoculated fish. Recombinant vaccines are also simpler to manufacture on a large-scale, commercial basis.

The injection vaccines segment witnessed growth at a rapid rate.

Injection vaccines dominated the market share for aquaculture vaccines. Injection vaccinations allow for the direct induction of a systemic immune response by delivering antigens directly into a bodily cavity or muscle. Injection vaccines' superior capacity to cure various bacterial and viral infectious diseases compared to other routes of administration is thus expected to boost industry statistics.

The European Aquaculture Vaccines market holds a significant revenue share in the region.

The European Aquaculture Vaccines market is expected to register the highest market share in revenue in the near future. The main drivers propelling this regional market include Norway's position as the region's largest salmon exporter, supportive government and business sector initiatives, growing public concern about the prevalence of antibiotic resistance, and the existence of significant companies. The Norwegian Medicines Agency has specific guidelines and recommendations for autogenous vaccination applications. Additionally, autogenous vaccinations should only be used when commercial vaccines are either not accessible or do not provide adequate protection. In addition, Asia Pacific is projected to expand in the global Aquaculture Vaccines market because of growing demand, a thriving aquaculture industry, encouraging government initiatives, adequate water resources in many regions, and a drive toward sustainable aquaculture, among other factors. Several aquatic species, including tilapia, are abundant in this area.

Competitive Landscape

Some major key players in the Aquaculture Vaccines market are Pharmaq AS (Zoetis, LLC) (Norway), Merck Animal Health (Merck & Co., Inc.) (USA), KoVax Ltd. (Part of Phibro Animal Health) (Israel), Hipra (Spain), Tecnovax SA (Argentina), Veterquimica S.A. (Chile), Nisseiken Co. Ltd. (Japan), Virbac S.A. (France), Elanco (USA) and Kyoritsuseiyaku Corporation (Japan).

Chapter 1. Methodology and Scope

1.1. Research Methodology

1.2. Research Scope & Assumptions

Chapter 2. Executive Summary

Chapter 3. Global Aquaculture Vaccines Market Snapshot

Chapter 4. Global Aquaculture Vaccines Market Variables, Trends & Scope

4.1. Market Segmentation & Scope

4.2. Drivers

4.3. Challenges

4.4. Trends

4.5. Investment and Funding Analysis

4.6. Industry Analysis – Porter’s Five Forces Analysis

4.7. Competitive Landscape & Market Share Analysis

4.8. Impact of Covid-19 Analysis

Chapter 5. Market Segmentation 1: by Vaccine Type Estimates & Trend Analysis

5.1. by Vaccine Type & Market Share, 2019 & 2030

5.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2030 for the following by Vaccine Type:

5.2.1. Inactivated Vaccine

5.2.2. Attenuated Live Vaccine

5.2.3. DNA Vaccine

5.2.4. Others

Chapter 6. Market Segmentation 2: by Application Estimates & Trend Analysis

6.1. by Application & Market Share, 2019 & 2030

6.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2030 for the following by Application:

6.2.1. Bacterial Infection

6.2.2. Viral Infections,

6.2.3. Combined Bacterial and Viral Infections

6.2.4. Others

Chapter 7. Market Segmentation 3: by Route of Administration Estimates & Trend Analysis

7.1. by Route of Administration & Market Share, 2019 & 2030

7.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2030 for the following by Route of Administration:

7.2.1. Immersion Vaccines

7.2.2. Injection Vaccines

7.2.3. Oral Vaccines

Chapter 8. Market Segmentation 4: by Species Estimates & Trend Analysis

8.1. by Species & Market Share, 2019 & 2030

8.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2030 for the following by Species:

8.2.1. Salmon

8.2.2. Seabass and Seabream

8.2.3. Tilapia

8.2.4. Trout

8.2.5. Turbot

8.2.6. Carp

Chapter 9. Aquaculture Vaccines Market Segmentation 5: Regional Estimates & Trend Analysis

9.1. North America

9.1.1. North America Aquaculture Vaccines Market Revenue (US$ Million) Estimates and Forecasts by Vaccine Type, 2022-2030

9.1.2. North America Aquaculture Vaccines Market Revenue (US$ Million) Estimates and Forecasts by Application, 2022-2030

9.1.3. North America Aquaculture Vaccines Market revenue (US$ Million) by Route of Administration, 2022-2030

9.1.4. North America Aquaculture Vaccines Market revenue (US$ Million) by Species, 2022-2030

9.1.5. North America Aquaculture Vaccines Market Revenue (US$ Million) Estimates and Forecasts by country, 2022-2030

9.2. Europe

9.2.1. Europe Aquaculture Vaccines Market revenue (US$ Million) by Vaccine Type, 2022-2030

9.2.2. Europe Aquaculture Vaccines Market revenue (US$ Million) by Application, 2022-2030

9.2.3. Europe Aquaculture Vaccines Market revenue (US$ Million) by Route of Administration, 2022-2030

9.2.4. Europe Aquaculture Vaccines Market revenue (US$ Million) by Species, 2022-2030

9.2.5. Europe Aquaculture Vaccines Market revenue (US$ Million) by country, 2022-2030

9.3. Asia Pacific

9.3.1. Asia Pacific Aquaculture Vaccines Market revenue (US$ Million) by Vaccine Type, 2022-2030

9.3.2. Asia Pacific Aquaculture Vaccines Market revenue (US$ Million) by Application, 2022-2030

9.3.3. Asia-Pacific Aquaculture Vaccines Market revenue (US$ Million) by Route of Administration, 2022-2030

9.3.4. Asia-Pacific Aquaculture Vaccines Market revenue (US$ Million) by Species, 2022-2030

9.3.5. Asia Pacific Aquaculture Vaccines Market revenue (US$ Million) by country, 2022-2030

9.4. Latin America

9.4.1. Latin America Aquaculture Vaccines Market revenue (US$ Million) by Vaccine Type, 2022-2030

9.4.2. Latin America Aquaculture Vaccines Market revenue (US$ Million) by Application, 2022-2030

9.4.3. Latin America Aquaculture Vaccines Market revenue (US$ Million) by Route of Administration, 2022-2030

9.4.4. Latin America Aquaculture Vaccines Market revenue (US$ Million) by Species, 2022-2030

9.4.5. Latin America Aquaculture Vaccines Market revenue (US$ Million) by country, 2022-2030

9.5. Middle East & Africa

9.5.1. Middle East & Africa Aquaculture Vaccines Market revenue (US$ Million) by Vaccine Type, 2022-2030

9.5.2. Middle East & Africa Aquaculture Vaccines Market revenue (US$ Million) by Application, 2022-2030

9.5.3. Middle East & Africa Aquaculture Vaccines Market revenue (US$ Million) by Route of Administration, 2022-2030

9.5.4. Middle East & Africa Aquaculture Vaccines Market revenue (US$ Million) by Species, 2022-2030

9.5.5. Middle East & Africa Aquaculture Vaccines Market revenue (US$ Million) by country, 2022-2030

Chapter 10. Competitive Landscape

10.1. Major Mergers and Acquisitions/Strategic Alliances

10.2. Company Profiles

10.2.1. Pharmaq AS (Zoetis, LLC) (Norway)

10.2.2. Merck Animal Health (Merck & Co., Inc.) (USA)

10.2.3. KoVax Ltd. (Part of Phibro Animal Health) (Israel)

10.2.4. Hipra (Spain)

10.2.5. Tecnovax SA (Argentina)

10.2.6. Veterquimica S.A. (Chile)

10.2.7. Nisseiken Co. Ltd. (Japan)

10.2.8. Virbac S.A. (France)

10.2.9. Elanco (USA)

10.2.10. Kyoritsuseiyaku Corporation (Japan)

10.2.11. Other Prominent Players

By Vaccine Type-

  • Inactivated Vaccine
  • Attenuated Live Vaccine
  • DNA Vaccine
  • Others

By Application-

  • Bacterial Infection
  • Viral Infections,
  • Combined Bacterial and Viral Infections
  • Others

By Route of Administration-

  • Immersion Vaccines
  • Injection Vaccines
  • Oral Vaccines

By Species-

  • Salmon
  • Seabass and Seabream
  • Tilapia
  • Trout
  • Turbot
  • Carp

By Region-

North America-

  • The US
  • Canada
  • Mexico

Europe-

  • Germany
  • The UK
  • France
  • Italy
  • Spain
  • Rest of Europe

Asia-Pacific-

  • China
  • Japan
  • India
  • South Korea
  • South East Asia
  • Rest of Asia Pacific

Latin America-

  • Brazil
  • Argentina
  • Rest of Latin America

 Middle East & Africa-

  • GCC Countries
  • South Africa
  • Rest of Middle East and Africa

InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.

Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.

Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.

Secondary research

The secondary research sources that are typically mentioned to include, but are not limited to:

  • Company websites, financial reports, annual reports, investor presentations, broker reports, and SEC filings.
  • External and internal proprietary databases, regulatory databases, and relevant patent analysis
  • Statistical databases, National government documents, and market reports
  • Press releases, news articles, and webcasts specific to the companies operating in the market

The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista

Primary Research:

Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies

The contributors who typically take part in such a course include, but are not limited to: 

  • Industry participants: CEOs, CBO, CMO, VPs, marketing/ type managers, corporate strategy managers, and national sales managers, technical personnel, purchasing managers, resellers, and distributors.
  • Outside experts: Valuation experts, Investment bankers, research analysts specializing in specific markets
  • Key opinion leaders (KOLs) specializing in unique areas corresponding to various industry verticals
  • End-users: Vary mainly depending upon the market

Data Modeling and Analysis:

In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.

The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.

To know more about the research methodology used for this study, kindly contact us/click here.

Need Complete Report ?
Our Clients